Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer

Summary

Because of the high risk for development of muscle invasive disease, cystectomy is recommended for CIS, high-grade Ta and T1 patients who experience disease recurrence following intravesical therapy. VB4-845 injection is an experimental agent that may provide an alternative to cystectomy

Timeline

Start

2021-03-23

Primary completion

2022-06

Completion

2023-12

Drugs

Indications